Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Sclerosis in Adults”

38 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 38 results

Testing effectiveness (Phase 2)Looking for participantsNCT06619561
What this trial is testing

Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)

Who this might be right for
Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC 48
Testing effectiveness (Phase 2)Active Not RecruitingNCT06843239
What this trial is testing

Tibulizumab Systemic Sclerosis Understanding and Response Evaluation (TibuSURE)

Who this might be right for
Systemic Sclerosis (SSc)Scleroderma
Zura Bio Inc 80
Not applicableStudy completedNCT04822038
What this trial is testing

Immunomodulating Effects of Supplementation With 25-OH Vitamin D

Who this might be right for
Vitamin D DeficiencyScleroderma, Systemic
Coordinación de Investigación en Salud, Mexico 49
Early research (Phase 1)Looking for participantsNCT06925542
What this trial is testing

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

Who this might be right for
SLE (Systemic Lupus)Lupus Erythematosus, SystemicLupus Nephritis+4 more
CRISPR Therapeutics 80
Early research (Phase 1)Study completedNCT00930683
What this trial is testing

Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma

Who this might be right for
Scleroderma
MedImmune LLC 34
Testing effectiveness (Phase 2)Looking for participantsNCT07641634
What this trial is testing

PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis.

Who this might be right for
Healthy VolunteersSystemic Sclerosis (SSc)Scleroderma, Systemic+1 more
Prolium Bioscience, Inc 44
Early research (Phase 1)Looking for participantsNCT07295847
What this trial is testing

AZD0120 in Autoimmune Diseases

Who this might be right for
Systemic SclerosisIdiopathic Inflammatory MyopathiesRheumatoid Arthritis
AstraZeneca 27
Early research (Phase 1)Enrolling By InvitationNCT06375993
What this trial is testing

Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease

Who this might be right for
Lupus NephritisAutoimmune DiseasesSystemic Sclerosis (SSc)+4 more
Adicet Therapeutics 180
Testing effectiveness (Phase 2)WithdrawnNCT04138485
What this trial is testing

Efficacy and Safety of IgPro10 in Adults With Systemic Sclerosis (SSc)

Who this might be right for
Diffuse Cutaneous Systemic Sclerosis
CSL Behring
Not applicableLooking for participantsNCT07515638
What this trial is testing

Immun4Cure Cohort of Autoimmune Diseases

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusSystemic Sclerosis+1 more
University Hospital, Montpellier 500
Large-scale testing (Phase 3)Study completedNCT03717961
What this trial is testing

Efficacy of Botulinum Toxin A in Adult Subjects With Raynaud Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud Phenomenon Secondary to Systemic Sclerosis
Assistance Publique - Hôpitaux de Paris 91
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07748000
What this trial is testing

LIQ861 (Inhaled Treprostinil) in Adults With Systemic Sclerosis Who Have Symptomatic Raynaud's Phenomenon Attacks

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Liquidia Technologies, Inc. 75
Early research (Phase 1)WithdrawnNCT06377228
What this trial is testing

TAK-007 in Adults With Refractory Lupus Nephritis (LN) or Refractory Systemic Sclerosis (SSc)

Who this might be right for
Refractory Lupus NephritisRefractory Systemic Sclerosis
Takeda
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07821398
What this trial is testing

Hyperpolarized Xenon MRI in Adults With Pulmonary Hypertension in Interstitial Lung Disease and Systemic Sclerosis

Who this might be right for
Interstitial Lung DiseasePulmonary HypertensionSystemic Sclerosis
Bastiaan Driehuys 51
Testing effectiveness (Phase 2)Ended earlyNCT04915950
What this trial is testing

Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Pfizer 13
Large-scale testing (Phase 3)Looking for participantsNCT05878717
What this trial is testing

The Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Who this might be right for
Systemic Sclerosis Associated Interstitial Lung DiseaseScleroderma, Systemic
GlaxoSmithKline 300
Testing effectiveness (Phase 2)UnknownNCT04927390
What this trial is testing

Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)

Who this might be right for
Systemic SclerosisLimited Cutaneous Systemic Sclerosis
University College, London 120
Testing effectiveness (Phase 2)Study completedNCT02260557
What this trial is testing

Effects of Selexipag in Adults With Raynaud's Phenomenon Secondary to Systemic Sclerosis

Who this might be right for
Raynaud's Phenomenon Secondary to Systemic Sclerosis
Actelion 74
Not applicableUnknownNCT01642706
What this trial is testing

Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments

Who this might be right for
Rheumatoid ArthritisOsteoarthritisSystemic Lupus Erythematosus+6 more
University Hospital, Montpellier 240
Testing effectiveness (Phase 2)Study completedNCT05559580
What this trial is testing

A Study in People With Systemic Sclerosis to Test Whether Avenciguat (BI 685509) Has an Effect on Lung Function and Other Systemic Sclerosis Symptoms

Who this might be right for
Scleroderma, Systemic
Boehringer Ingelheim 214
Next Page